Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC)

Clinical trial NCT04831450 · WITHDRAWN

Trial details

NCT number: NCT04831450
Sponsor: University of Miami
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma HNSCC Squamous Cell Carcinoma of the Larynx Squamous Cell Carcinoma of the Oral Cavity Squamous Cell Carcinoma of Hypopharynx

Start date: 2022-07-01
Primary completion: 2022-07-15
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.